Amgen is the latest to raise drug prices despite public outcry
Amgen Profit Rises 13%, 2016 Outlook Raised -- Update
UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback
Amgen Biosimilar Gets Thumbs-Up From FDA Panel
UPDATE: These drugs could cut American health costs by $250 billion (if only we could take them)
UPDATE: These drugs could cut American health -2-
©2014 Morningstar Advisor. All right reserved.